Tweet
Medical Marketing and Media
<img alt="" height="1" width="1" />
Pfizer's Pneumonia Vaccine Meets Targets in Post-Approval Study
Businessweek
Pfizer Inc. (PFE:US)'s pneumonia vaccine met the goals of a study that was required by U.S. regulators when the therapy was approved for patients at least 50 years old. The clinical trial called Capita showed the vaccine worked against a first episode of ...
Childhood infection vaccine Pfizer Prevnar 13 also good for helping elderly ward ...Tech Times
Pfizer Prevnar data could boost Rx numbersMedical Marketing and Media
Pfizer reports its huge trial of Prevnar has met its primary and secondary goalsFierceVaccines
Reuters -News Tonight Africa -Wall St. Cheat Sheet
all 31 news articles »
More...